Technical Analysis for NICXF - Nicox Sa EUR Ord

Grade Last Price % Change Price Change
grade F 4.96 -1.98% -0.1000
NICXF closed down 1.98 percent on Friday, August 16, 2019, on 5 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical NICXF trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -1.98%
Narrow Range Bar Range Contraction -1.98%
New 52 Week Low Weakness -1.98%

Older signals for NICXF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Nicox S.A., an ophthalmic company, researches, develops, and markets therapies that target various ophthalmic conditions in France and internationally. The company's product pipeline includes VyzultaTM, an intraocular pressure-lowering treatment; and NCX 470, a nitric oxide (NO)-donating candidate to treat glaucoma, as well as stand-alone NO donors for specific applications in ophthalmic diseases. It also develops ZERVIATE, an eye drop formulation of cetirizine for allergic conjunctivitis; NCX 4280, an ophthalmic solution that targets morning ocular congestion; and NCX 4251, a patented formulation of fluticasone propionate to treat blepharitis. The company has collaborations with Bausch + Lomb, Astra Zeneca, Merck, Pfizer, and Ironwood Pharmaceuticals, Inc., as well as Novaliq GmbH. Nicox S.A. was founded in 1996 and is headquartered in Valbonne, France.
Medicine Health Medical Specialties Glaucoma Conjunctivitis Allergic Conjunctivitis
Is NICXF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 14.8466
52 Week Low 4.96
Average Volume 1,974
200-Day Moving Average 0.0
50-Day Moving Average 7.6996
20-Day Moving Average 5.9247
10-Day Moving Average 5.2923
Average True Range 0.2289
ADX 30.97
+DI 28.5795
-DI 70.2755
Chandelier Exit (Long, 3 ATRs ) 6.9633
Chandelier Exit (Short, 3 ATRs ) 5.6467
Upper Bollinger Band 7.2709
Lower Bollinger Band 4.5785
Percent B (%b) 0.14
BandWidth 45.443651
MACD Line -0.6965
MACD Signal Line -0.7173
MACD Histogram 0.0208
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.9600
Resistance 3 (R3) 4.9600 4.9600 4.9600
Resistance 2 (R2) 4.9600 4.9600 4.9600 4.9600
Resistance 1 (R1) 4.9600 4.9600 4.9600 4.9600 4.9600
Pivot Point 4.9600 4.9600 4.9600 4.9600 4.9600
Support 1 (S1) 4.9600 4.9600 4.9600 4.9600 4.9600
Support 2 (S2) 4.9600 4.9600 4.9600 4.9600
Support 3 (S3) 4.9600 4.9600 4.9600
Support 4 (S4) 4.9600